A randomised placebo-controlled clinical study to assess the safety and tolerability of Capsifen and its efficacy on energy expenditure

Akay Flavours and Aromatics Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1)Male or female healthy volunteers who have been practicing exercise or training
•sessions for a minimum period of last 1 month to manage the obesity
•2)Age 21-40 Years ( Both Inclusive)
•3)Subjects with Body Mass Index (BMI) between 27Kg/m to 40 Kg/m
•4)Shall agree to sign an Informed Consent Document

•1)Subject with history of cardiovascular, Type 2 Diabetes mellitus, pulmonary, hepatic, gastrointestinal problems, and renal problems
•2)Subjects with a history of anorexia nevosa or other eating disorders
•3)Subjects with known history of gastrointestinal irregularities
•4)Prior use of anti obesity agents
•5)History of surgical therapy for obesity
•6)Subjects with known genetical syndromes which cause obesity
•7)Subjects who are currently under any kind of long term medication
•8)Subjects with a known allergy to herbal products
•9)Subjects with abnormal biochemical or haematological values
•10)Pregnant or Lactating Women
•11)Any condition that in Opinion of the Investigator, does not justify the Subjectsâ?? participation in the study.

发起方

Akay Flavours and Aromatics Private Limited